DKDaiki Kojima

Daiki Kojima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daiki Kojima has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Kaori Hayashi

    Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

    4 shared publications
  • Hiroshi Itoh

    Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

    3 shared publications
  • Takeshi Kanda

    Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

    3 shared publications
  • Jun Yoshino

    Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan

    2 shared publications
  • Kenji Kaneko

    Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

    2 shared publications
  • Ryunosuke Mitsuno

    Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

    2 shared publications

Latest Publications

  • Open Access

    Vascular Endothelial NAMPT ‐Mediated NAD + Biosynthesis Regulates Angiogenesis and Cardiometabolic Functions in Male Mice

    by Shotaro Kosugi, Shintaro Yamaguchi, Ken Nishioka, Taichi Nagahisa, Yasuhiro Watanabe, Daiki Kojima, Kenji Kaneko, Ryunosuke Mitsuno, Ran Nakamichi, Yoshinaga Kawano, et al.

    Aging is associated with metabolic dysfunction and cardiovascular abnormalities. Defective nicotinamide adenine dinucleotide (NAD + ) biosynthesis correlates with aging and aging‐associated complications. However, the precise molecular mechanisms linking aging‐associated NAD + deficiency to cardiometabolic dysfunction remain unclear. Herein, we examined whether nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD + biosynthesis, influences vascular endothelial function and whole‐body metabolic and hemodynamic homeostasis during aging. Vascular endothelial cell–specific Nampt knockout (VeNKO) mice fed a regular chow diet exhibited no cardiometabolic abnormalities, whereas male VeNKO mice fed a high‐fat diet exhibited reduced angiogenesis, resulting in impaired subcutaneous adipogenesis, impaired glucose metabolism, and hemodynamic disturbances. Mechanistically, NAMPT loss attenuated NAD + ‐dependent deacetylase sirtuin‐1 (SIRT1) and endothelial nitric oxide synthase (eNOS) signaling, impairing angiogenesis. Aged mice exhibited endothelial NAD + depletion driven by an imbalance between NAMPT‐mediated NAD + biosynthesis and consumption, leading to impaired eNOS signaling and associated angiogenic and cardiometabolic dysfunction, similar to that observed in VeNKO mice. Nicotinamide mononucleotide administration replenished vascular endothelial NAD + levels, improved angiogenesis, restored subcutaneous adipose tissue volume, and ameliorated aging‐associated cardiometabolic dysfunction. Collectively, our findings provide mechanistic and therapeutic insights into vascular endothelial NAMPT–NAD + –SIRT1–eNOS signaling related to aging‐associated cardiometabolic disorders.


  • Adipocyte-specific inactivation of NAMPT, a key NAD+ biosynthetic enzyme, causes a metabolically unhealthy lean phenotype in female mice during aging

    by Nathan Qi, Michael P. Franczyk, Shintaro Yamaguchi, Daiki Kojima, Kaori Hayashi, Akiko Satoh, Noboru Ogiso, Takeshi Kanda, Yo Sasaki, Brian N. Finck, et al.

    Defective NAD+ metabolism is associated with aging and age-associated metabolic diseases. In the present study, we provided in-depth metabolic assessments in female mice with adipocyte-specific inactivation of a key NAD+ biosynthetic enzyme NAMPT and revealed an unexpected role of adipose tissue NAMPT-NAD+-PPAR-γ axis in maintaining functional integrity and quantity of adipose tissue and whole body metabolic health during the aging process.


  • Adipocyte NMNAT1 expression is essential for nuclear NAD+ biosynthesis but dispensable for regulating thermogenesis and whole-body energy metabolism

    by Shintaro Yamaguchi, Daiki Kojima, Tooba Iqbal, Shotaro Kosugi, Michael P. Franczyk, Nathan Qi, Yo Sasaki, Keisuke Yaku, Kenji Kaneko, Kenichiro Kinouchi, et al.


  • Open Access

    Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis

    by Shun Tonomura, Kiyotaka Uchiyama, Takashin Nakayama, Ryunosuke Mitsuno, Daiki Kojima, Eriko Yoshida Hama, Tomoki Nagasaka, Erina Sugita Nishimura, Ei Kusahana, Rina Takahashi, et al.

    Introduction: We aimed to determine the correlation between the serum urea‐to‐creatinine ratio and residual kidney function (RKF) in patients undergoing peritoneal dialysis (PD), as well as its predictive value for PD‐related outcomes.Methods: This study included a cross‐sectional study to assess the correlation between serum urea‐to‐creatinine ratio and RKF in 50 patients on PD and a retrospective cohort study to assess the association between serum urea‐to‐creatinine ratio and PD‐related outcomes in 122 patients who initiated PD.Results: Serum urea‐to‐creatinine ratios had significant positive correlations with renal Kt/V and creatinine clearance values (r = 0.60, p < 0.001 and r = 0.61, p < 0.001, respectively). Additionally, serum urea‐to‐creatinine ratio was significantly associated with a lower risk of transfer to hemodialysis or PD/hemodialysis hybrid therapy (hazard ratio: 0.84, 95% confidence interval: 0.75–0.95).Conclusion: The serum urea‐to‐creatinine ratio can be an indicator of RKF and a prognostic factor in patients undergoing PD.